We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

352820:KRXHYBE Co., Ltd. Analysis

Data as of 2026-09-09 - not real-time

₩174,200.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

HYBE Co., Ltd. is priced at KRW 174,200.00 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 19.4% over the past 30 days. Relative strength is 50.2 — neutral — and the MACD signal is bullish. The recent range runs from support at KRW 162,800.00 up to resistance at KRW 188,300.00.
The shares look fair, trading on 18.7 times earnings above a sector average of 15.3. Analyst price targets sit 94.0% above the current price. Revenue is growing at 105.5% on a -10.3% profit margin. The 0.28% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 68.5%, a beta of 0.39 and a maximum drawdown of 59.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Barron's19dHYBE Co. Ltd.HYBE Co., Ltd. engages in the entertainment, intellectual property, and platform businesses....Barron's6monHYBE Co. Ltd.HYBE Co., Ltd. engages in the entertainment, intellectual property, and platform businesses....

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 270071.00
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 18.7 versus sector average of 15.3
  • Trading below the 200-day average of 270071.00

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 18.7 versus sector average of 15.3
  • Negative profit margin of -10.3%
  • Analyst targets imply +94.0% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth105.50%
Profit Margin-10.35%
P/E Ratio18.7
ROE-10.29%
ROA-0.71%
Debt/Equity26.42
Op. Cash Flow₩130.1B
Free Cash Flow₩273.6B
Industry P/E15.3

Technical Analysis

TrendBearish
RSI50.2
Support₩162,800.00
Resistance₩188,300.00
MA 20₩176,755.00
MA 50₩190,396.00
MA 200₩270,071.00
MACDBullish
VolumeStable
Fear & Greed Index92.45

Valuation

Fair Value₩239,068.01
Target Price₩337,916.66
Upside/Downside93.98%
GradeFair
TypeGrowth
Dividend Yield0.28%

Risk Assessment

Beta0.39
Volatility68.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.